Back to Archived Journals » Oncolytic Virotherapy » Volume 4

Myxoma virus attenuates expression of activating transcription factor 4 (ATF4) which has implications for the treatment of proteasome inhibitor–resistant multiple myeloma

Total article views   HTML views PDF downloads Totals
8,660 Dovepress* 8,318+ 1,292 9,610
PubMed Central* 342 98 440
Totals 8,660 1,390 10,050
*Since 13 January 2015
+Since July 2016

View citations on PubMed Central and Google Scholar